Table 3.
NOS-based quality analysis of the included studies
| Study | Selection | Comparability | Exposure/Outcome | Overall |
|---|---|---|---|---|
| Anand et al., 2021[22] | **** | ** | *** | Low |
| Marouf et al., 2021 [25] | **** | ** | *** | Low |
| Larvin et al 2020 [29] | *** | ** | *** | Low |
| Gupta et al. 2021 [23] | *** | ** | ** | Low |
| Holt et al. 2021 [40] | ** | * | *** | Moderate |
| Donders et al 2022 [31] | *** | ** | *** | Low |
| Larvin et al 2021 [30] | *** | ** | ** | Low |
| Costa 2022 [37] | *** | ** | ** | Low |
| Kaur et al 2022 [42] | ** | * | *** | Moderate |
| Mishra et al 2022 [44] | *** | ** | ** | Low |
| Kamel et al. 2021 [24] | *** | * | * | Moderate |
| Sirin & Ozcelik 2021 [47] | ** | * | ** | Moderate |
| Koppolu et al., 2023 [43] | ** | ** | *** | Low |
| Sari et al., 2023 [46] | ** | * | ** | Moderate |
| Said et al., 2023 [27] | **** | ** | *** | Low |
| Alnomay et al., 2023 [35] | ** | ** | ** | Moderate |
| Guardado-Luevanos et al., 2022 [38] | ** | ** | *** | Low |
| Gujar et al., 2022 [39] | ** | ** | *** | Low |
| Wadhwa et al. 2022 [26] | *** | ** | *** | Low |
| Poyato-Borrego et al., 2023 [45] | **** | ** | *** | Low |
| Kalsi et al., 2023 [41] | *** | ** | *** | Low |
| Bemquerer et al., 2023 [36] | ** | ** | ** | Moderate |